APTEKA 282, OAO, Samara Oblast

Economic indicators

Net profit (RAS) of APTEKA 282, OAO grew over 2018 5.79 times to 4.98 million RUB from 859.00 thousand RUB over 2017, the company informed.

Revenue decreased in the accounting period by 11.28% to 3.38 million RUB from 3.80 million RUB in 2017; cost of goods sold grew by 0.50% to 1.21 million RUB from 1.21 million RUB; sales profit went up by 1.42% to 1.29 million RUB from 1.27 million RUB.

Net profit (RAS) of APTEKA 282, OAO grew over 2017 2.19 times to 859.00 thousand RUB from 392.00 thousand RUB over 2016, the company informed.

Revenue increased in the accounting period by 11.92% to 3.80 million RUB from 3.40 million RUB over 2016; cost of goods sold decreased by 5.04% to 1.21 million RUB from 1.27 million RUB; sales profit went up 1.85 times to 1.27 million RUB from 684.00 thousand RUB.

Net profit (RAS) of APTEKA 282, OAO dropped in 2016 2.38 times to 392.00 thousand RUB from 932.00 thousand RUB over the same period in 2015, the company informed.

Revenue decreased in the accounting period by 9.77% to 3.40 million RUB from 3.77 million RUB in 2015; cost of goods sold decreased by 12.59% to 1.27 million RUB from 1.45 million RUB; sales profit fell by 30.42% to 684.00 thousand RUB from 983.00 thousand RUB.

Net profit (RAS) of Apteka 282, OAO grew over 2014 1.77 times to 1.10 million RUB from 623.00 thousand RUB over 2013, the company informed.

Revenue increased in the accounting period by 24.75% to 4.79 million RUB from 3.84 million RUB over 2013; cost of goods sold decreased by 15.61% to 1.51 million RUB from 1.79 million RUB; sales profit went up 1.78 times to 1.24 million RUB from 694.00 thousand RUB.

Net profit (RAS) of Apteka 282, OAO dropped in 2013 by 19.92% to 623.00 thousand RUB from 778.00 thousand RUB over the same period in 2012, the company informed.

Revenue decreased in the accounting period by 9.49% to 3.84 million RUB from 4.25 million RUB in 2012; cost of goods sold decreased by 16.67% to 1.79 million RUB from 2.15 million RUB; sales profit fell by 17.58% to 694.00 thousand RUB from 842.00 thousand RUB.

Net profit (RAS) of Apteka 282, OAO grew over 2012 9.60 times to 778.00 thousand RUB from 81.00 thousand RUB over 2011, the company informed.

Revenue decreased in the accounting period by 12.09% to 4.25 million RUB from 4.83 million RUB in 2011; cost of goods sold decreased by 24.07% to 3.40 million RUB from 4.48 million RUB.

Companies in the region

• UK INVEST-MENEDZHMENT
• FORINT
• FIU
• METALLKOMPLEKT
• INTRA